RE:RE:Former Spectral Chair and BoD member shine for TRIL!For once I have to agree with you (about moving the needle). As with the previous umpteen investor presentations, that have done zippo for stock price and interest (aka volume). , I am not getting my hopes that there will be any difference this time. According to the company's last "investor presentation" they are a year out from any FDA trial being completed/submitted, never mind being reviewed and given the 'thumbs up'!!
But it is probably according to the company's "strategy" (gawd I only wish I knew what that could be!)
As for the IR characters, they are BRUTAL in responding over the years. So much for promoting the company.